Review Article
Cytokines and Chemokines in Neuropsychiatric Syndromes of Systemic Lupus Erythematosus
Table 3
CHemokines in CSF of NPSLE.
| Chemokines | NPSLE | Control group | Authors | Year |
| MCP-1/CCL2 | Increased | Non-NPSLE | Iikuni et al. [7] | 2006 | Increased | Non-NPSLE | Fragoso-Loyo [21] | 2007 | RANTES/CCL5 | Increased | Non-NPSLE | Fragoso-Loyo [21] | 2007 | IL-8/CXCL8 | Increased | Non-NPSLE | Trysberg et al. [43] | 2003 | Increased | Non-NPSLE, SM, non-AID | Fragoso-Loyo [21] | 2007 | Increased | MS, other AID | Santer et al. [22] | 2009 | IP-10/CXCL10 | Increased | Non-NPSLE | Okamoto et al. [9] | 2004 | Fractalkine | Increased | Non-NPSLE | Yajima et al. [45] | 2005 | Same | Non-NPSLE | Sato et al. [46] | 2006 | IP-10/MCP-1 ratio | Increased | Non-NPSLE | Okamoto et al. [8] | 2006 |
|
|
AID: autoimmune diseases, MS: multiple sclerosis, SM: septic meningitis.
|